Multiple Myeloma
Showing NaN - NaN of 109
Maintenance With Bortezomib Plus Daratumumab After Induction
Recruiting
- Multiple Myeloma
- Non-eligible for Autologous Stem Cell Transplantation (ASCT)
-
Arganda Del Rey, Spain
- +31 more
Sep 15, 2022
Multiple Myeloma Trial in Worldwide (Daratumumab, Carfilzomib, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- Daratumumab
- +4 more
-
Nantes Cedex 1, France
- +19 more
Aug 11, 2022
Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Pomalidomide)
Recruiting
- Multiple Myeloma
- Elranatamab
- +3 more
-
Woolloongabba, Queensland, Australia
- +117 more
Aug 3, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)
Active, not recruiting
- Multiple Myeloma
- Belantamab mafodotin frozen liquid
- Belantamab mafodotin lyophilized powder
-
New Haven, Connecticut
- +58 more
Jul 27, 2022
Multiple Myeloma Trial in Worldwide (Carfilzomib Lenalidomide Dexamethasone, Isatuximab Carfilzomib Lenalidomide Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib Lenalidomide Dexamethasone
- Isatuximab Carfilzomib Lenalidomide Dexamethasone
-
Ostrava, Czechia
- +6 more
Jul 26, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Bortezomib, Lenalidomide)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Yuma, Arizona
- +34 more
Jul 22, 2022
Multiple Myeloma Trial in Worldwide (Lemzoparlimab, Dexamethasone, Carfilzomib)
Terminated
- Multiple Myeloma
- Lemzoparlimab
- +4 more
-
Tucson, Arizona
- +58 more
Jul 6, 2022
Multiple Myeloma Trial in Worldwide (Belantamab mafodotin, Pomalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Belantamab mafodotin
- +3 more
-
Tucson, Arizona
- +131 more
Jul 1, 2022
Multiple Myeloma Trial in Worldwide (BL-8040 1.25mg/kg + G-CSF, Placebo +G-CSF)
Active, not recruiting
- Multiple Myeloma
- BL-8040 1.25mg/kg + G-CSF
- Placebo +G-CSF
-
Los Angeles, California
- +17 more
Jun 14, 2022
Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))
Completed
- Lymphoma
- Multiple Myeloma
- Lenalidomide
- +4 more
-
Muscle Shoals, Alabama
- +215 more
May 5, 2022
Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma
- Ixazomib
- +3 more
-
Badalona, Spain
- +7 more
May 20, 2022
Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone, Bortezomib)
Terminated
- Multiple Myeloma
- Melphalan flufenamide (Melflufen)
- +3 more
-
Boston, Massachusetts
- +15 more
Mar 4, 2022
Presentation, Treatment Patterns, and Outcomes in Multiple
Completed
- Multiple Myeloma
- No Intervention
-
Little Rock, Arkansas
- +136 more
Feb 15, 2022
Multiple Myeloma Trial in Worldwide (Melphalan flufenamide (Melflufen), Dexamethasone)
Completed
- Multiple Myeloma
- Melphalan flufenamide (Melflufen)
- Dexamethasone
-
Whittier, California
- +19 more
Feb 2, 2022
Multiple Myeloma Trial in Spain (Clarithromycin, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Clarithromycin
- +2 more
-
A Coruña, Spain
- +25 more
Jan 17, 2022